Divi’s Laboratories Limited is one of the world’s leading manufacturers of active pharmaceutical ingredients (APIs), custom synthesis products, and nutraceutical ingredients. Established in 1990 by Dr. Murali K. Divi, the company has earned a strong reputation for supplying high-quality pharmaceutical intermediates and APIs to leading global pharmaceutical companies. Divi’s operates an integrated business model encompassing process research, custom manufacturing, contract development, and large-scale commercial production. The company serves customers across more than 100 countries and maintains long-term partnerships with several multinational pharmaceutical innovators. Its state-of-the-art manufacturing facilities comply with stringent international regulatory standards, including approvals from the US FDA, EMA, PMDA, and other global authorities. Divi’s continues to invest in process innovation, sustainability, and operational efficiency while expanding its portfolio of high-value APIs and nutraceutical ingredients. Its strong focus on quality, reliability, and technological excellence has positioned the company among the world’s premier pharmaceutical ingredient manufacturers.
NSE: DIVISLAB | BSE: 532488
Hyderabad, Telangana, India
~18,000 employees
